The FDA has just approved the fast acting insulin Apidra to be used in a clinical setting in an inraveneous route. This is good news for both type 1 and type 2 diabetics that are hospitalized and are in need for glycemic control.
Apidra is a rapid-acting insulin that offers patients mealtime dosing...







This article is courtesy of dLife Today
BD Changes Insulin Syringe Package Labeling | Why excess body fat contributes to type 2 diabetes | Diabetes and Fitness

Add to Google
Technorati tags: blood presure • diabetes • glucose monitor • insulin • sugar levels
Flickr tags: blood presure • diabetes • glucose monitor • insulin • sugar levels
Tags: blood presure, diabetes, glucose monitor, insulin, sugar levels
Categories: News
Add To My Favourites